Laboratory of human genes structure and functions
Department of Genetics and Postgenomic Technologies
Head: Eugeny Sverdlov, member of the academy of sciences
Main results
Genomics of cis-regulatory elements (L.G. Nikolaev, S.B. Akopov, I.P. Chernov, T.L. Azhikina)
Publication of nucleotide sequences of several eukaryotic genomes opened up a possibility to study the regulatory mechanisms determining the phenotypic variability of living organisms. Mammalian genome contains up to 30,000 protein-coding genes, and much larger portion of the genome is transcribed. Both genes and transcribed genome regions of a multicellular organism are participate in complex regulated network that determines the existence of many specialized cell types. Transcription of genes and non-coding sequences is regulated at several levels: linear genome architecture represented by DNA cis-regulatory elements, modifications of DNA, chromatin structure, compartmental organization of the nucleus etc.
Despite the achievements in a study of individual regulatory systems, we are still far away from complete understanding of the mechanisms that regulate the genome as a whole. Even in the relatively simple cases of cis-regulators identification we encounter serious problems which demand great efforts from many researchers to be solved. For example, it is predicted that human genome may contain up to 100,000 enhancers and silencers, but only small part of them is characterized to date.
A very important part of genome regulatory machinery are epigenetic elements, i.e. elements determining stably inherited changes in gene expression level without change of DNA sequence. Among them are sites of DNA methylation, regions containing modified histones etc. In mammals, methylation of CpG sites plays a key role in gene regulation by means of either modification of cis-regulatory elements or modification of long genome region which is associated with chromatin conformation change. To elucidate the mechanisms of methyl-dependent regulation of expression the detailed maps of methylation of long genomic regions are necessary. A comparison of these maps for different types of cells may reveal how DNA methylation affects gene expression.
In our lab several methods are developed allowing a high-throughput identification and genome mapping of non-methylated CpG dinucleotides, transcription start sites, and several genomic regulatory elements — nuclear matrix attachment sites (S/MARs), insulators, enhancers, open and closed chromatin regions, and binding sites of DNA-recognizing proteins including transcription factors, within long
Integrated map of regulatory elements positions within 500 kb human chromosome 19 region. Vertical color lines indicate positions of corresponding regulatory elements.
Structure and functional study of Mycobacterium tuberculosis, Burkholderia pseudomallei and Burkholderia mallei pathogenesis (T.L. Azhikina, G.S. Monastyrskaya)
Tuberculosis — a chronic infection caused by Gram-positive bacteria Mycobacterium tuberculosis — is one of ten world’s main causes of premature death and second among infections. Mycobacterial genome is extremely variable that complicates tuberculosis diagnostics and therapy. We developed the experimental method of comparative analysis of the genomes — the RFLP subtractive hybridization — which allows comparing genomes of closely related bacterial strains. With the use of this system a comparison of the genomes of different M. tuberculosis strains circulating in Russia and causing different clinical manifestations of the disease was performed. Basing on the differential sequences obtained the experimental approach was developed allowing to study an insertion-deletion polymorphism within Russian population of M. tuberculosis
M. tuberculosis caused human infection with a wide spectrum of clinical manifestations that depends on complex and not completely studied interactions between host and bacterium. We are studying a full spectrum of transcripts of the M. tuberculosis genes during primary infection and after the transition into chronic and latent forms. This will help to reveal the hoe the pathogen escapes from host response. In collaboration with the immunogenetics lab of Central Institute for Tuberculosis (Head Prof. A.S. Apt) we developed a method allowing for analysis of the intracellular pathogen’s transcriptome directly in infected tissues. The method may be useful for search of virulence factors, targets for drug therapy and for development of the epidemiological monitoring strategy for any pathogen.
In collaboration with State Scientific Center of Applied Microbiology (I. Abaev) the whole-genome comparison of pathogenic Burkholderia pseudomallei
Position of differential fragments found (circles) on the M. tuberculosis deletion genome map. The map reflects non-random distribution of the deleted regions. The numbers indicate genomic distance (in megabases), 0 — replication start site.
Approaches to diagnostics and gene therapy of cancer (T.V. Vinogradova, E.P. Kopantzev, I.P. Chernov)
Currently much attention is paid to development of new generation therapy of cancer. Within the framework of the State program «Priority fields in science and technology in Russia during
Hence, the bases were established for the development and production of novel effective medical preparations and diagnostics based on gene therapy approach and biologically active proteins.
Cancer and development (M.V. Zinovyeva, T.V. Vinogradova, G.S. Monastyrskaya)
Demonstration of the fact that genes that are activated during development of lung and esophagus in embryogenesis are switched off in normal cells when they are being transformed into cancer cells and conversely is one the major achievements of the project. This confirms the hypothesis that process of cancer transformation and progression of normal cells may be compared with embryonal development or self-reproduction and differentiation of stem cells of certain tissues. The genes that express differentially in cancer and development probably play key role in tumorigenesis. Study of such genes allows carrying out a rational choice of therapeutic targets because systems regulating embryonal development and damaged in cancer are most perspective targets.
Modified oligonucleotides (V.K. Potapov)
Development of new methods of production and synthesis of modified oligonucleotides with changed structure of the base or of sugar-phosphate skeleton was the mainstream of the group through the last three years. Working out of approaches to solid phase synthesis of morpholino-analogues of oligonucleotides, which have morpholine ring in their structure instead of ribose, is the most perspective direction of the research. Such analogues are uncharged molecules and resistant to nucleases. They preserve DNA structure and form stable complementary bonds with native oligonucleotides.
Synthesis of oligonucleotides bearing spacers of specified length with thiol group in certain sites is the second direction of the work. These oligonucleotides are used in study of their complexes with integrases of HIV and ASV
| Name | Position | Sergej B. Akopov, ph. d. | s. r. f. | akser@ibch.ru | Ljudmila V. Averina | eng. | Tatyana L. Azhikina, d. sc. | s. r. f. | tatazhik@ibch.ru | Nina N. Beljaeva, ph. d. | r. f. | . Biltueva | PhD stud. | bjuliya87@mail.ru | Irina V. Boni, ph. d. | s. r. f. | irina_boni@ibch.ru | Svetlana S. Bulanenkova, ph. d. | r. f. | Igor' P. Chernov, ph. d. | r. f. | igor_ch@ibch.ru | Dmitry . Didych, ph. d. | r. f. | dmitry_d@inbox.ru | Ol'ga B. Filjukova, ph. d. | r. f. | Kirill N. Kashkin, ph. d. | r. f. | Ljudmila S. Koledinskaja | j. r. f. | Evgenij P. Kopancev, ph. d. | s. r. f. | kopantzev@ibch.ru | Zoja B. Kravchenko | res. eng. | Tat'jana L. Levitan | res. eng. | levitanibh@mail.ru | Natalija I. Medvedeva | res. eng. | Galina S. Monastyrskaya, ph. d., senior research associate | l. r. f. | gal@ibch.ru | Lev G. Nikolaev, d. sc. | s. r. f. | lev@ibch.ru | Oxana Y. Ovchinnikova, ph. d. | ovchox@gmail.com | Rudolf A. Pogosyan | j. r. f. | r.j.f@mail.ru | Viktor K. Potapov, d. sc. | l. r. f. | vk@ibch.ru | Aleksandr V. Sass | j. r. f. | Nadezhda V. Skapcova | r. f. | Timofey A. Skvortsov, ph. d. | r. f. | timofey@ibch.ru | Evgeny V. Snezhkov, ph. d. | s. r. f. | eugene@ibch.ru | Nataliya Y. Uspenskaya, ph. d. | s. r. f. | usp@ibch.ru | Tat'jana V. Vinogradova, ph. d. | s. r. f. | tv@ibch.ru | Ljudmila L. Zavalova, ph. d. | s. r. f. | lz@ibch.ru | Marina V. Zinov'eva, ph. d. | r. f. | mzinov@ibch.ru |
|---|



